Targeting ubiquitin-independent proteasome with small molecule increases susceptibility in pan-KRAS-mutant cancer models. Shen S, Zhang Q, Wang Y, Chen H, et al. J Clin Invest 2025;135:e185278.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shen S, Zhang Q, Wang Y, Chen H, et al. Targeting ubiquitin-independent proteasome with small molecule increases susceptibility in pan-KRAS-mutant cancer models. J Clin Invest 2025;135:e185278.
PMID: 40091835